Declining mortality in older people with type 2 diabetes masks rising excess risks at younger ages: a population-based study of all-cause and cause-specific mortality over 13 years.

BACKGROUND Excess mortality in people with vs without type 2 diabetes (T2DM) has fallen, but it is unclear whether men/women at all ages have benefited and which causes of death have driven these trends. METHODS All-cause and cause-specific mortality rates and excess mortality [by mortality rate ratios (MRRs) relative to the non-diabetic general population] were examined in 1 268 018 Australians with T2DM registered on the National Diabetes Services Scheme (2002-2014). RESULTS Age-standardized mortality decreased in men (-2.2%/year; Ptrend < 0.001) and women with T2DM (-1.3%/year; Ptrend < 0.001) throughout 2002-14, which translated to declines in the MRRs (from 1.51 to 1.45 in men; 1.59 to 1.46 in women; Ptrend < 0.05 for both). Declining mortality rates in T2DM were observed in men aged 40+ years and women aged 60+ years (Ptrends <0.001), but not at younger ages. However, the only age group in which excess mortality declined relative to those without diabetes was 80+ years (Ptrends < 0.05); driven by reductions in excess cancer-related deaths in men and cardiovascular disease (CVD) in women. Among age groups <80 years, CVD and cancer MRRs remained similar or increased over time, despite falls in both CVD and cancer mortality rates. MRRs for non-CVD/non-cancer-related deaths increased in 60-79 year-olds, but were otherwise unchanged. CONCLUSIONS Declining excess mortality attributable to T2DM from 2002-14 was driven entirely by reductions in those aged 80+ years. Declines in total mortality among those with T2DM were apparent in more age groups, but often to a lesser extent than in the general population, thereby serving to increase the excess risk associated with T2DM.

[1]  A. Kong,et al.  Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study , 2020, Diabetologia.

[2]  H. Weir,et al.  Trends in cancer mortality among people with vs without diabetes in the USA, 1988–2015 , 2019, Diabetologia.

[3]  S. Saydah,et al.  The Cardiometabolic Risk Profile of Young Adults With Diabetes in the U.S. , 2019, Diabetes Care.

[4]  C. Reid,et al.  Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  W. Herman,et al.  Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing , 2019, Diabetes Care.

[6]  S. Grant,et al.  Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II , 2018, Internal medicine journal.

[7]  L. Geiss,et al.  Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data , 2018, The Lancet.

[8]  J. Shaw,et al.  Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011 , 2018, Diabetologia.

[9]  S. Edelman,et al.  Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014 , 2017, Diabetes Therapy.

[10]  C. Fischbacher,et al.  Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013 , 2016, Diabetologia.

[11]  Naveed Sattar,et al.  The changing face of diabetes complications. , 2016, The lancet. Diabetes & endocrinology.

[12]  J. Shaw,et al.  Age-Specific Trends From 2000–2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People , 2016, Diabetes Care.

[13]  M. Woodward,et al.  Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia , 2015, Diabetes Care.

[14]  D. Magliano,et al.  Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 Diabetes , 2015, Diabetes Care.

[15]  J. Shaw,et al.  Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation , 2014, Diabetes Care.

[16]  J. Shaw,et al.  Mortality Trends Among People With Type 1 and Type 2 Diabetes in Australia: 1997–2010 , 2014, Diabetes Care.

[17]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.

[18]  L. Lipscombe,et al.  Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study , 2013, Diabetologia.

[19]  J. Saaddine,et al.  Achievement of goals in U.S. diabetes care, 1999-2010. , 2013, The New England journal of medicine.

[20]  S. Gapstur,et al.  Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults , 2012, Diabetes Care.

[21]  K. Borch-Johnsen,et al.  The Danish National Diabetes Register: trends in incidence, prevalence and mortality , 2008, Diabetologia.

[22]  Keith G. Tolman,et al.  Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease , 2007 .

[23]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[24]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[25]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .